
PALISADE BIO, INC.
PALISADE BIO, INC. (PALI)
WebsitePrice
Market cap
Next catalystExpected Q1 2027PALI-2108 — planned ASCENTRA-CD · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
Partner / License out
History / paused
PALI PR & News
PR & News
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
PALISADE BIO, INC.
Publications